why choose us

Clinical Trials Search

Showing 7,660 of 132,656 result(s)
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed;Refractory Non-Hodgkin Lymphomas

Status: Completed

Condition: Relapsed;Refractory Non-Hodgkin Lymphoma

Interventions: Specified dose on specified days.

Date: 2023-10-13

Treating Major Depression With Yoga Mono-therapy

Status: NOT_YET_RECRUITING

Condition: Depression Mild

Interventions: 90-minute group yoga classes twice weekly for 12 weeks.

Date: 2023-10-13

Incremental PD With Single Icodextrin Exchange

Status: NOT_YET_RECRUITING

Condition: Peritoneal Dialysis Complication

Interventions: PD initiation with single daily exchange of 2-liter icodextrin-based dialysis solution.

Date: 2023-10-13

Trial Evaluating Both Tolerability and Improvement for Signs of Facial Photoaging, Discoloration, and Texture in Adult Females of All Skin Types by Combining a Placebo Moisturizer and Non-ablative Laser.

Status: NOT_YET_RECRUITING

Condition: Photoaging

Interventions: The non-ablative fractional 1,927nm Thulium laser will be used in this study.
This FDA-approved laser is an innovative device addressing as well

Date: 2023-10-13

Knee Biofeedback Rehabilitation Through Game Therapy

Status: NOT_YET_RECRUITING

Condition: Knee Osteoarthritis

Interventions: The KneeBRIGHT system includes electromyogram sensors and video game software that leads participants through physical therapy exercise.

Date: 2023-10-13

Autologous CAR-T Cells Targeting CSPG4 in Relapsed;Refractory HNSCC

Status: NOT_YET_RECRUITING

Condition: Head and Neck Cancer

Interventions: cyclophosphamide 300 mg;meter square IV

Date: 2023-10-13

DMT310-009 Topical in the Treatment of Acne Vulgaris

Status: Completed

Condition: Acne Vulgaris

Interventions: Topical Powder

Date: 2023-10-13

Molecular Services and EMR-Lab Integration Application (ELIA) for Reducing Healthcare Disparities in Cancer Patients

Status: NOT_YET_RECRUITING

Condition: Advanced Cancer

Interventions: TSO500; detect single nucleotide variants (SNV), INDELs, copy number alterations (CNAs), microsatellite instability (MSI), and tumor mutation burden (

Date: 2023-10-13